Active substances extracted from animal organs can enhance the body's metabolism and disease resistance, help blood cell proliferation, differentiation, maturation and release, and have a good effect on increasing white blood cells and platelets.

By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls and inhibits or kills bacteria. When used in combination with trimethoprim, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage.

By inhibiting bacterial transpeptidase, it prevents the synthesis of bacterial cell walls and inhibits or kills bacteria. When used in combination with cephalexin, it can enhance antibacterial ability, delay the development of drug resistance, and reduce oral dosage.

It has good effects on Escherichia coli, Klebsiella, Proteus, Shigella, Enterobacter, Serratia and Pseudomonas aeruginosa. Neisseria and Haemophilus influenzae are moderately sensitive to this product. It also has certain effects on Brucella, Yersinia pestis, Acinetobacter and Campylobacter fetus. It has good antibacterial effects on about 80% of methicillin-sensitive strains of Staphylococcus, but most methicillin-resistant strains are resistant to this product. It has poor effects on Streptococcus and Streptococcus pneumoniae, and Enterococcus is mostly resistant to this product. When this product is used in combination with β-lactams, most of them can obtain synergistic antibacterial effects. Its mechanism of action is to bind to the 30S subunit of the bacterial ribosome and inhibit the synthesis of bacterial proteins. In recent years, the number of gram-negative bacteria resistant to gentamicin has increased significantly.

It can play a protective antacid and astringent role on the gastrointestinal mucosa, and can achieve an antidiarrheal effect by reducing intestinal irritation, preventing the body from excessive dehydration and water-salt metabolism disorders.

It has a strong antibacterial effect on most anaerobic bacteria, and its bactericidal mechanism has not yet been fully elucidated. The nitroreductase of anaerobic bacteria plays an important role in the energy metabolism of sensitive strains. The nitro group of this product is reduced to a cytotoxin, thereby acting on the DNA metabolism process of bacteria and promoting cell death.

It is a long-acting non-steroidal anti-inflammatory analgesic. After entering the body, it is metabolized into diphenyl ethyl ester, which can inhibit the activity of cyclooxygenase, reduce the synthesis of prostaglandins, and produce anti-inflammatory, analgesic and antipyretic effects.

Cephalexin is a first-generation cephalosporin. It is sensitive to most strains of Streptococcus pneumoniae, hemolytic Streptococcus, and penicillinase-producing or non-producing Staphylococci. It has a good antibacterial effect on Neisseria and a certain antibacterial effect on some Escherichia coli, Proteus mirabilis, Salmonella and Shigella.

Trimethoprim is an antibacterial agent that acts by interfering with bacterial folate metabolism.